Journal article
Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: a Mendelian Randomisation study
Abstract
Abstract Fibroblast growth factor 23 (FGF-23) is associated with a range of cardiovascular and non-cardiovascular diseases in conventional epidemiological studies, but substantial residual confounding may exist. Mendelian randomisation approaches can help control for such confounding. SCALLOP consortium data on 19,195 participants were used to generate an FGF-23 genetic score. Data from 337,448 UK Biobank participants were used to estimate …
Authors
Donovan K; Herrington WG; Paré G; Pigeyre M; Haynes R; Sardell R; Butterworth AS; Folkersen L; Gustafsson S; Wang Q
Journal
, , ,
Publisher
Cold Spring Harbor Laboratory
DOI
10.1101/2022.04.27.22273667